相似文献
1
Accelerometry: Improving Objective Assessments of Therapeutic Impact in Pediatric Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2017 Jul 15;196(2):127-129. doi: 10.1164/rccm.201702-0409ED.
2
Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.
Am J Respir Crit Care Med. 2017 Jul 15;196(2):220-227. doi: 10.1164/rccm.201608-1576OC.
3
[PRIMARY PULMONARY ARTERIAL HYPERTENSION. APROPOS OF 8 PERSONAL OBSERVATIONS].
Mal Cardiovasc. 1965;6:121-38.
4
Baloon atrial septostomy in pulmonary arterial hypertension: Atrial flow regulator - New therapeutic option.
Cardiol J. 2017;24(4):455-456. doi: 10.5603/CJ.2017.0094.
5
[Considerations on primary pulmonary hypertension in children].
Arch Fr Pediatr. 1962 Nov;19:1165-84.
6
[On a case of idiopathic pulmonary hypertension in a child (preliminary note)].
Riv Anat Patol Oncol. 1962 Apr;21:xvi-xix.
7
Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
Eur Respir J. 2019 Mar 28;53(3). doi: 10.1183/13993003.00005-2019. Print 2019 Mar.
8
[The mechanisms of inflammation in pulmonary arterial hypertension.].
Zhonghua Jie He He Hu Xi Za Zhi. 2009 Nov;32(11):862-5.
9
Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
Eur Respir J. 2019 Mar 28;53(3). doi: 10.1183/13993003.00135-2019. Print 2019 Mar.
10
Primary pulmonary hypertension in childhood.
Br Heart J. 1961 Nov;23(6):605-15. doi: 10.1136/hrt.23.6.605.
本文引用的文献
1
Physical Activity in Pediatric Pulmonary Arterial Hypertension Measured by Accelerometry. A Candidate Clinical Endpoint.
Am J Respir Crit Care Med. 2017 Jul 15;196(2):220-227. doi: 10.1164/rccm.201608-1576OC.
2
Translating Research into Improved Patient Care in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2017 Mar 1;195(5):583-595. doi: 10.1164/rccm.201607-1515PP.
3
Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.
Heart. 2016 May;102 Suppl 2:ii86-100. doi: 10.1136/heartjnl-2015-309132.
4
Systematic review of the validity and reliability of consumer-wearable activity trackers.
Int J Behav Nutr Phys Act. 2015 Dec 18;12:159. doi: 10.1186/s12966-015-0314-1.
5
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society.
Circulation. 2015 Nov 24;132(21):2037-99. doi: 10.1161/CIR.0000000000000329. Epub 2015 Nov 3.
6
Beyond the 6-Minute Walk Test for Assessing Pediatric Pulmonary Hypertension: Making Strides Through Combination End Points.
Chest. 2015 Sep;148(3):576-577. doi: 10.1378/chest.15-0779.
7
Management of pulmonary arterial hypertension.
J Am Coll Cardiol. 2015 May 12;65(18):1976-97. doi: 10.1016/j.jacc.2015.03.540.
8
Clinical Worsening as Composite Study End Point in Pediatric Pulmonary Arterial Hypertension.
Chest. 2015 Sep;148(3):655-666. doi: 10.1378/chest.14-3066.
9
Survival differences in pediatric pulmonary arterial hypertension: clues to a better understanding of outcome and optimal treatment strategies.
J Am Coll Cardiol. 2014 May 27;63(20):2159-2169. doi: 10.1016/j.jacc.2014.02.575. Epub 2014 Mar 26.
10
Macitentan and morbidity and mortality in pulmonary arterial hypertension.
N Engl J Med. 2013 Aug 29;369(9):809-18. doi: 10.1056/NEJMoa1213917.
Zotero 插件